Background-Tobacco use prevention programmes need accurate information about smoking related mortality. Beginning in 1989, Oregon began asking physicians to report on death certificates whether tobacco use contributed to the death. Objective-To determine the long term comparability of this method of estimating tobacco attributable mortality to estimates of smoking attributable mortality derived from a computer model. Design-For the period 1989 to 1996, we compared mortality resulting from tobacco use reported by Oregon physicians to estimates of smoking attributable deaths (SADs) derived by "Smoking attributable mortality, morbidity and economic costs" software version 3.0 (SAMMEC 3.0), a widely used software program that estimates SADs on the basis of smoking prevalence and relative risks of specific diseases among current and former smokers. Main outcome measures-Numbers of deaths, age, sex, and category of disease. Results-Of 212 448 Oregon deaths during 1989-1996, SAMMEC 3.0 estimated that 42 778 (20.1%) were attributable to cigarette smoking. For the same 27 diagnoses, physicians reported that tobacco contributed to 42 839 (20.2%) deaths-a cumulative diVerence of only 61 deaths over the eight year period. The age and sex distributions of tobacco and smoking attributable deaths reported by the two systems were also similar. By category of disease, the ratio of SAMMEC 3.0 estimates to physician reported deaths was 1.11 for neoplasms, 0.88 for heart disease, and 1.04 for respiratory disease. Conclusions-Physician reporting provides comparable estimates of smoking attributable mortality and can be a valuable source of data for communicating the risks of tobacco use to the public. (Tobacco Control 2001;10:161-164) 
As states struggle to decide how to spend the funds from the settlement with the tobacco industry and consider allocating other resources to tobacco prevention, controversy over the actual burden of disease from tobacco and the merit of funding tobacco prevention programmes will arise. Not only do public health oYcials need to quantify the burden of smoking related mortality accurately, they must convey these numbers to legislators and the public in a convincing manner. The Centers for Disease Control and Prevention's "Smoking-attributable mortality, morbidity and economic costs" software version 3 (SAM-MEC 3.0) is a widely used software program that estimates smoking attributable deaths (SADs).
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For purposes of public health advocacy and education, however, physician reports may be more believable to the public than estimates derived from computer models.
In 1989, Oregon became the first of nine states or cities (Colorado, Louisiana, Maryland, Nebraska, North Dakota, Oregon, Texas, Utah, and New York City) to ask physicians to report on death certificates whether tobacco use contributed to the death. A preliminary comparison of SADs derived from SAMMEC 3.0 and tobacco attributable deaths reported by Oregon physicians found similar results using both methods.
2 However, whether this finding would persist over time has remained questionable. The objective of this study was to determine the long term comparability of physician reporting as a method of estimating smoking attributable mortality.
Methods

PHYSICIAN REPORTS
When completing death certificates, physicians first list the underlying or primary cause of death, followed by contributory causes, or secondary conditions that may have contributed to the death. Since January 1989, Oregon death certificates have included the question: "Did tobacco use contribute to the death?" Physicians are required to check one of four possible responses: yes, probably, no, or unknown. Health division personnel routinely contact the certifying physician when a box is not checked, or the response does not appear logical; for the period 1989 to 1996, fewer than 1% of death certificates required physician follow up. For the purpose of this analysis, we defined physician reported, tobacco attributable deaths (TADs) as deaths among persons for whom physicians reported that tobacco contributed to or probably contributed to their deaths. (Although physician reporting diVers from SAMMEC 3.0 in that it measures mortality caused by tobacco, while SAMMEC *International classification of diseases, 9 th edition. †Combines deaths from rheumatic heart disease, pulmonary heart disease, and cardiac arrest/other heart disease. ‡Combines deaths from respiratory tuberculosis and asthma. 35-64 years and 65 and older, and pregnant women, Oregon, 1988 35-64 years and 65 and older, and pregnant women, Oregon, -1995 35-64 years and 65 and older, and pregnant women, Oregon, 1988 35-64 years and 65 and older, and pregnant women, Oregon, 1989 35-64 years and 65 and older, and pregnant women, Oregon, 1990 35-64 years and 65 and older, and pregnant women, Oregon, 1991 35-64 years and 65 and older, and pregnant women, Oregon, 1992 35-64 years and 65 and older, and pregnant women, Oregon, 1993 35-64 years and 65 and older, and pregnant women, Oregon, 1994 35-64 years and 65 and older, and pregnant women, Oregon, 1995 fig 1) . SAMMEC 3.0 estimates of deaths from neoplasms were only slightly higher than physician reported deaths from these causes; the average ratio of SAMMEC 3.0 estimates to physician reports was 1.11 with a range of 1.07-1.17. SAMMEC 3.0 generated slightly lower numbers of deaths from heart disease than those reported by physicians (average ratio 0.88, range 0.80-0.98). Deaths from respiratory disease estimated by SAMMEC 3.0 most closely matched the numbers reported by physicians, with an average ratio of 1.04 (range 1.02-1.11). Finally, although not shown by year, the overall ratio of SAMMEC 3.0 estimates of SADs to physician estimates of TADs from perinatal conditions and burn deaths was 6.82 and 2.04, respectively (table 2) . The sex and age distributions of tobacco and smoking attributable deaths reported by the two systems were also remarkably similar. Physicians reported that 61.6% of TADs occurred among men compared with SAMMEC 3.0's estimate of 62.6%. By year, physician reported deaths in men diVered from SAMMEC estimates by < 3%. Overall, the median age at death for TADs reported by physicians was 73 and by year was either 72 or 73. For SAMMEC 3.0, the median age of death was 74 overall and ranged from 73-75 by year.
Lastly, we examined the 46 321 deaths during the period 1993-1996 that did not have an underlying cause of death recognised by SAM-MEC 3.0 as aetiologically linked to smoking (table 3) . During 1993-1996, physicians reported that 3477 (7.5%) of these deaths were related to tobacco. Of these 3477 physician reported deaths, 2227 (64.0%) listed a contributing, or secondary, cause of death that fell into one of the 27 SAMMEC 3.0 categories; this proportion was similar by year (range 62.3-65.6%). Compared with other deaths from underlying causes of death not recognised by SAMMEC 3.0 that physicians did not link to tobacco, deaths reported by physicians as related to tobacco were more than twice as likely to have a contributing cause of death aetiologically linked to tobacco. Additionally, we reviewed the underlying causes of death for the 1250 deaths that physicians reported were linked to tobacco but that did not have an underlying or contributory cause of death that fell into one of the 27 SAMMEC 3.0 categories. Four hundred and seventy one (37.1%) fell into the general category of neoplasms (International classification of diseases, ninth revision (ICD-9) codes 140-239), but no single cancer predominated. The remaining 729 deaths were widely distributed over a range of underlying causes of death, including digestive diseases (ICD-9 codes 520-579), mental disorders (ICD-9 codes 290-319), and endocrine, nutritional, and metabolic diseases and immunity disorders (ICD-9 codes 240-279). Oregon, 1989 -1996 Oregon, 1993 Oregon, -1996 . 
Discussion
For the 27 SAMMEC diagnoses, SAMMEC 3.0 and physician reports provided similar estimates over the entire eight year period, suggesting that physician reporting and SAM-MEC 3.0 are comparable methods of estimating smoking attributable mortality. Small discrepancies did exist: SAMMEC 3.0 estimated more deaths from neoplasms, whereas physicians reported more deaths from heart disease. Although physician estimates of deaths from lung cancer closely matched those produced by SAMMEC 3.0, they greatly underestimated SADs from cervical, oesophageal, and pancreatic cancer, suggesting a lack of knowledge of the link between smoking and these conditions. The multifactorial nature of heart disease makes it diYcult to assign the specific risk factor responsible for the death on an individual basis, possibly leading physicians to overestimate the role of tobacco in this condition. Alternatively, physician reporting on death certificates may be more accurate than SAMMEC 3.0 for cardiovascular deaths; physicians are more sensitive to a patient's history of smoking behaviour and of the relation between smoking, age, and other comorbidities that are also smoking related that may have contributed to the patient's death. SAMMEC 3.0 also estimated higher numbers of deaths from perinatal conditions and burn deaths than physicians reported. Although deaths from these conditions comprised less than 0.01% of SADs estimated by either method and did not greatly aVect overall mortality estimates, it is interesting to note that physicians appear reluctant to attribute deaths from these conditions to tobacco use. It may be that physicians may not consider the role of tobacco when the deceased is not a smoker, as may happen when an infant dies of sudden infant death syndrome or the family member of a smoker dies in a fire in the home. Physicians' systematic under reporting of deaths from certain categories of deaths such as burns, perinatal conditions, and non-lung neoplasms points to the need for both medical education and media and public awareness campaigns that draw more attention to the role of tobacco in these conditions.
In some instances, physician reporting on death certificates may be more accurate than estimates derived by SAMMEC 3.0. One shortfall of SAMMEC 3.0 is its inability to consider contributing causes of death in estimating SADs. Our review of physician reported TADs from underlying causes of death not recognised by SAMMEC 3.0 found that most had a contributing cause of death that could be linked to cigarette smoking, suggesting that physician reports may result in a better estimate of smoking related mortality. Secondly, SAMMEC 3.0 estimates are based on current estimates of the prevalence of current and former smokers. After quitting smoking, the risk of death from the 27 underlying causes of death falls at diVerent rates for the diVerent diseases, and SAMMEC 3.0 does not take into consideration the length of time since the individual quit smoking. Physicians are in a better position to utilise cessation information, while SAMMEC 3.0 is fairly inflexible in this regard. For tracking smoking attributable mortality in settings where anti-smoking programmes have been implemented and smoking prevalence is changing rapidly, physician reporting may be more valid.
Finally, physician reporting can be a valuable source of data for risk communication to the public. Persuading legislators or the public that tobacco prevention programmes deserve public funding requires convincing evidence of the burden of smoking attributable morbidity and mortality. Estimates derived locally from trusted sources (for example, physicians) may be more useful for this purpose than from methods considered more methodologically sound by epidemiologists. 
